These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1419630)

  • 21. Autoantibodies and lymphoproliferative diseases in acquired C1-inhibitor deficiencies.
    Cicardi M; Zingale LC; Pappalardo E; Folcioni A; Agostoni A
    Medicine (Baltimore); 2003 Jul; 82(4):274-81. PubMed ID: 12861105
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The critical concentration of C1-esterase inhibitor (C1-INH) in human serum preventing auto-activation of the first component of complement (C1).
    Windfuhr JP; Alsenz J; Loos M
    Mol Immunol; 2005 Apr; 42(6):657-63. PubMed ID: 15781109
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Hereditary angioedema: changes in serum levels of C4 in response to danazol].
    Egidio Fabiani J; Squiquera L; Leoni J; Simkin G; Casala A
    Med Cutan Ibero Lat Am; 1987; 15(6):461-7. PubMed ID: 3323703
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prospective analysis of C1 dissociation and complement activation in patients with systemic lupus erythematosus.
    Jonsson H; Sturfelt G; Mårtensson U; Truedsson L; Sjöholm AG
    Clin Exp Rheumatol; 1995; 13(5):573-80. PubMed ID: 8575134
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Beneficial effects of C1 esterase inhibitor in ST-elevation myocardial infarction in patients who underwent surgical reperfusion: a randomised double-blind study.
    Fattouch K; Bianco G; Speziale G; Sampognaro R; Lavalle C; Guccione F; Dioguardi P; Ruvolo G
    Eur J Cardiothorac Surg; 2007 Aug; 32(2):326-32. PubMed ID: 17576071
    [TBL] [Abstract][Full Text] [Related]  

  • 26. C1- inactivator: its efficiency as a regulator of classical complement pathway activation by soluble IgG aggregates.
    Doekes G; van Es LA; Daha MR
    Immunology; 1983 Jun; 49(2):215-22. PubMed ID: 6852866
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acquired C1 esterase inhibitor deficiency in lymphomas: prevalence, symptoms, and response to treatment.
    Bekos C; Perkmann T; Krauth M; Raderer M; Lechner K; Jaeger U
    Leuk Lymphoma; 2016 Sep; 57(9):2033-6. PubMed ID: 26795750
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytokines associated with amyloid plaques in Alzheimer's disease brain stimulate human glial and neuronal cell cultures to secrete early complement proteins, but not C1-inhibitor.
    Veerhuis R; Janssen I; De Groot CJ; Van Muiswinkel FL; Hack CE; Eikelenboom P
    Exp Neurol; 1999 Nov; 160(1):289-99. PubMed ID: 10630213
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma C1 inhibitor in malignant diseases: functional activity versus concentration.
    Starcević D; Jelić-Ivanović Z; Kalimanovska V
    Ann Clin Biochem; 1991 Nov; 28 ( Pt 6)():595-8. PubMed ID: 1776810
    [TBL] [Abstract][Full Text] [Related]  

  • 30. C1-inhibitor--biochemical properties and clinical applications.
    Al-Abdullah IH; Greally J
    Crit Rev Immunol; 1985; 5(4):317-30. PubMed ID: 3899511
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Simultaneous turnover of normal and dysfunctional C1 inhibitor as a probe of in vivo activation of C1 and contact activatable proteases.
    Woo P; Lachmann PJ; Harrison RA; Amos N; Cooper C; Rosen FS
    Clin Exp Immunol; 1985 Jul; 61(1):1-8. PubMed ID: 4042415
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro effects of organic solvents on immunity indicators in serum.
    Stefanovic J; Starsia Z; Murgasová I; Absolonová O
    J Hyg Epidemiol Microbiol Immunol; 1987; 31(1):1-7. PubMed ID: 3571967
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Baseline level of functional C1-inhibitor correlates with disease severity scores in hereditary angioedema.
    Kelemen Z; Moldovan D; Mihály E; Visy B; Széplaki G; Csuka D; Füst G; Farkas H; Varga L
    Clin Immunol; 2010 Mar; 134(3):354-8. PubMed ID: 19945350
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relevance of lymphoproliferative disorders and of anti-C1 inhibitor autoantibodies in acquired angio-oedema.
    Cicardi M; Beretta A; Colombo M; Gioffré D; Cugno M; Agostoni A
    Clin Exp Immunol; 1996 Dec; 106(3):475-80. PubMed ID: 8973615
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of the ficolin-lectin pathway during attacks of hereditary angioedema.
    Csuka D; Munthe-Fog L; Hein E; Zotter Z; Prohászka Z; Farkas H; Varga L; Garred P
    J Allergy Clin Immunol; 2014 Dec; 134(6):1388-1393.e1. PubMed ID: 25042985
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low c1-inhibitor levels predict early restenosis after eversion carotid endarterectomy.
    Széplaki G; Varga L; Laki J; Dósa E; Rugonfalvi-Kiss S; Madsen HO; Prohászka Z; Kocsis A; Gál P; Szabó A; Acsády G; Karádi I; Selmeci L; Garred P; Füst G; Entz L
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2756-62. PubMed ID: 17916775
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The acquired C1-INH deficiencies with autoantibodies (AAE type II).
    Alsenz J; Loos M
    Behring Inst Mitt; 1989 Jul; (84):165-72. PubMed ID: 2679532
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Unique C1 inhibitor dysfunction in a kindred without angioedema. I. A mutant C1 INH that inhibits C1-s but not C1-r.
    Wisnieski JJ; Knauss TC; Yike I; Dearborn DG; Narvy RL; Naff GB
    J Immunol; 1994 Mar; 152(6):3199-209. PubMed ID: 8144914
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Control of C1 activation by nascent C3b and C4b: a mechanism of feedback inhibition.
    Ziccardi RJ
    J Immunol; 1986 May; 136(9):3378-83. PubMed ID: 3485688
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibody-independent activation of C1. II. Evidence for two classes of nonimmune activators of the classical pathway of complement.
    Peitsch MC; Kovacsovics TJ; Tschopp J; Isliker H
    J Immunol; 1987 Mar; 138(6):1871-6. PubMed ID: 3029223
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.